Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
neoMONARCH: Abemaciclib + Anastrozole in Early Breast Cancer
NCT02441946Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of abemaciclib in breast cancer, sponsored by Eli Lilly and Company. Started Aug 2015; status: completed.
02
Drugs
abemaciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02441946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02441946.